TF
BMY icon

Tudor Financial’s Bristol-Myers Squibb BMY Stock Holding History

Tudor Financial’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$306K Buy
5,318
+12
+0.2% +$689 0.14% 126
2026
Q1 		$322K Buy
5,306
+14
+0.3% +$816 0.16% 115
2025
Q4 		$285K Sell
5,292
-1,185
-18% -$57K 0.15% 126
2025
Q3 		$292K Sell
6,477
-22
-0.3% -$1.03K 0.16% 121
2025
Q2 		$301K Sell
6,499
-458
-7% -$22.5K 0.17% 118
2025
Q1 		$424K Buy
6,957
+396
+6% +$23.1K 0.25% 94
2024
Q4 		$371K Buy
6,561
+1,727
+36% +$96.5K 0.22% 105
2024
Q3 		$250K Buy
+4,834
New +$227K 0.15% 118

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Tudor Financial's BMY Position: Q2 2026 in Review

Tudor Financial increased its Bristol-Myers Squibb (BMY) stake by 0.23% in Q2 2026, buying an estimated $689 and bringing the position to 5,318 shares worth $306K. The position accounts for 0.14% of the portfolio, ranked #126.

Tudor Financial first reported a position in BMY in Q3 2024 and has held it in 8 quarters since. The position peaked at $424K in Q1 2025. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Tudor Financial held 5,318 shares of Bristol-Myers Squibb worth $306K as of Q2 2026.
  • Tudor Financial bought 12 Bristol-Myers Squibb shares in Q2 2026, an estimated $689.
  • Bristol-Myers Squibb made up 0.14% of Tudor Financial's portfolio in Q2 2026, its #126 holding.
  • Tudor Financial first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 8 quarters since.
  • Tudor Financial's Bristol-Myers Squibb position peaked at $424K in Q1 2025.
  • 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Tudor Financial's 13F filing for Q2 2026, filed 6 Aug 2026.